1 |
Duranre C, Grani G, Lamartinna L, et al. The diagnosis and management of thyroid nodules: a review [J]. JAMA, 2018, 319(9): 914-924.
|
2 |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J]. Thyroid, 2016, 26(1): 1-133.
|
3 |
中华医学会内分泌学分会, 中华医学会外科学分会内分泌学组, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南 [J]. 中华内分泌代谢杂志, 2012, 28(10): 779-797.
|
4 |
中国医师协会超声医师分会. 甲状腺微小乳头状癌热消融诊疗指征专家共识 [J/CD]. 中华医学超声杂志(电子版), 2019, 16(8): 571-574.
|
5 |
Cho SJ, Baek JH, Chung SR, et al. Thermal ablation for small papillary thyroid cancer: a systematic review [J]. Thyroid, 2019, 29(12): 1774-1783.
|
6 |
Cho SJ, Baek SM, Lim HK, et al. Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors [J]. Thyroid, 2020, 30(12): 1745-1751.
|
7 |
Ding M, Tang X, Cui D, et al. Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma [J]. Clin Radiol, 2019, 74(9): 712-717.
|
8 |
Lim HK, Cho SJ, Baek JH, et al. US-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: efficacy and safety in a large population [J]. Korean J Radiol, 2019, 20(12): 1653-1661.
|
9 |
Zhang MB, Tufano RP, Russell JO, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years' follow-up [J]. Thyroid, 2020, 30(3): 408-417.
|
10 |
Xiao J, Zhang MB, Zhang Y, et al. Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T1bN0M0 papillary thyroid carcinoma: a retrospective study [J]. Int J Hyperthermia, 2020, 37(1): 392-398.
|
11 |
马亚辉. 移动消融与固定消融技术在微波消融甲状腺良性结节中的疗效对比分析 [D]. 蚌埠: 蚌埠医学院, 2018.
|
12 |
Park HS, Baek JH, Park AW, et al. Thyroid radiofrequency ablation: updates on innovative devices and techniques [J]. Korean J Radiol, 2017, 18(4): 615-623.
|
13 |
王昭波, 马亚辉, 陈兆永, 等. 杠杆撬离法和液体隔离带法在甲状腺良性结节微波消融术中预防喉返神经损伤的应用 [J]. 江苏医药, 2018, 44(8): 915-918.
|
14 |
杨映弘, 颜璟, 吴艳军, 等. 液体隔离带法与杠杆撬离法在超声引导下甲状腺微波消融术中的应用比较 [J]. 中国现代普通外科进展, 2018, 21(1): 28-30.
|
15 |
Zhu Y, Zhang MB, Jin Z, et al. Solid benign thyroid nodules (>10 ml): a retrospective study on the efficacy and safety of sonographically guided ethanol ablation combined with radiofrequency ablation [J]. Int J Hyperthermia, 2020, 37(1): 157-167.
|
16 |
Lekht I, Gulati M, Nayyar M, et al. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone [J]. Abdom Radiol (NY), 2016, 41(8): 1511-1521.
|
17 |
Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version) [J]. Ultraschall Med, 2018, 39(2): e2-e44.
|
18 |
Papini E, Pacella CM, Solbiati LA, et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group [J]. Int J Hyperthermia, 2019, 36(1): 376-382.
|
19 |
Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria [J]. Thyroid, 2019, 29(5): 611-618.
|
20 |
Mainini AP, Monaco C, Pescatori LC, et al. Image-guided thermal ablation of benign thyroid nodules [J]. J Ultrasound, 2017, 20(1): 11-22.
|
21 |
Lim HK, Lee JH, Ha EJ, et al. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients [J]. Eur Radiol, 2013, 23(4): 1044-1049.
|
22 |
Sim JS, Baek JH. Long-term outcomes following thermal ablation of benign thyroid nodules as an alternative to surgery: the importance of controlling regrowth [J]. Endocrinol Metab (Seoul), 2019, 34(2): 117-123.
|
23 |
Baek JH, Ha EJ, Choi YJ, et al. Radiofrequency versus ethanol ablation for treating predominantly cystic thyroid nodules: a randomized clinical trial [J]. Korean J Radiol, 2015, 16(6): 1332-1340.
|
24 |
Xiaoyin T, Ping L, Dan C, et al. Risk assessment and hydrodissection technique for radiofrequency ablation of thyroid benign nodules [J]. J Cancer, 2018, 9(17): 3058-3066.
|
25 |
Zhao CK, Xu HX, Lu F, et al. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: First results of CEUS evaluation [J]. Clin Hemorheol Microcirc, 2017, 65(4): 393-405.
|
26 |
Kim HS, Choi BH, Park JR, et al. Delayed surgery for parathyroid adenoma misdiagnosed as a thyroid nodule and treated with radiofrequency ablation [J]. Endocrinol Metab (Seoul), 2013, 28(3): 231-235.
|
27 |
Negro R, Greco G, Deandrea M, et al. Twelve-month volume reduction ratio predicts regrowth and time to regrowth in thyroid nodules submitted to laser ablation: a 5-year follow-up retrospective study [J]. Korean J Radiol, 2020, 21(6): 764-772.
|
28 |
Yue WW, Wang SR, Li XL, et al. Quality of life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules: a retrospective cohort study [J]. Sci Rep, 2016, 6: 37838.
|
29 |
Valcavi R, Tsamatropoulos P. Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: a 2-year follow-up study in 40 patients [J]. Endocr Pract, 2015, 21(8): 887-896.
|
30 |
Zhang MB, Luo YK, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study [J]. Thyroid, 2016, 26(11): 1581-1587.
|
31 |
Choi Y, Jung SL. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis [J]. Thyroid, 2020, 30(5): 720-731.
|
32 |
Zhang Y, Zhang MB, Luo YK, et al. Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma [J]. Cancer Med, 2019, 8(12): 5450-5458.
|
33 |
Lan Y, Luo YK, Zhang MB, et al. Quality of life in papillary thyroid microcarcinoma patients undergoing radiofrequency ablation or surgery: a comparative study [J]. Front Endocrinol (Lausanne), 2020, 11: 249.
|
34 |
Hay ID. Management of patients with low-risk papillary thyroid carcinoma [J]. Endocr Pract, 2007, 13(5): 521-533.
|
35 |
Suh CH, Baek JH, Choi YJ, et al. Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: a systematic review and meta-analysis [J]. Thyroid, 2016, 26(3): 420-428.
|
36 |
Chung SR, Baek JH, Choi YJ, et al. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer [J]. Eur Radiol, 2019, 29(9): 4897-4903.
|
37 |
Ma B, Wei W, Xu W, et al. Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: a retrospective case review and literature review [J]. Thyroid, 2018, 28(9): 1134-1142.
|
38 |
Bae J, Kim H, Ryu W, et al. Primary papillary thyroid carcinoma previously treated incompletely with radiofrequency ablation [J]. J Cancer Res Ther, 2010, 6(3): 310-312.
|
39 |
董文武, 张浩, 张平, 等. 甲状腺乳头状癌射频消融治疗后再手术5例临床分析 [J]. 中国实用外科杂志, 2015, 35(6): 653-655.
|
40 |
Kim JH, Yoo WS, Park YJ, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm [J]. Radiology, 2015, 276(3): 909-918.
|
41 |
Kim SY, Kim SM, Chang H, et al. Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer [J]. Eur Arch Otorhinolaryngol, 2017, 274(9): 3497-3501.
|
42 |
Al-Saif O, Farrar WB, Bloomston M, et al. Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer [J]. J Clin Endocrinol Metab, 2010, 95(5): 2187-2194.
|